Assessing rare diseases prevalence using literature quantification

Abstract

Introduction Estimating the prevalence of diseases is crucial for the organization of healthcare. The amount of literature on a rare pathology could help differentiate between rare and very rare diseases. The objective of this work was to evaluate to what extent the number of publications can be used to predict the prevalence of a given pathology. Methods We queried Orphanet for the global prevalence class for all conditions for which it was available. For these pathologies, we cross-referenced the Orphanet, MeSH, and OMIM vocabularies to assess the number of publication available on Pubmed using three different query strategies (one proposed in the literature, and two built specifically for this study). We first studied the association of the number of publications obtained by each of these query strategies with the prevalence class, then their predictive ability. Results Class prevalence was available for 3128 conditions, 2970 had a prevalence class < 1/1,000,000, 41 of 1–9/1,000,000, 84 of 1–9/100,000, and 33 of 1–9/10,000. We show a significant association and excellent predictive performance of the number of publication, with an AUC over 94% for the best query strategy. Conclusion Our study highlights the link and the excellent predictive performance of the number of publications on the prevalence of rare diseases provided by Orphanet.

How to deal with rare pediatric surgical diseases in the small developing country with limited resources: Insights from Bosnia and Herzegovina

“…The European Union Regulation on Orphan Medicinal Products defines a disease/condition as rare if it affects < 1 in 2.000 in the European population [1], making the prevalence data a key tool in creating health care policies for patients with rare diseases (RD) [2]. There is approximately 7.000 RD, mainly genetic [3], affecting approximately 30 million people in Europe and between 25 and 30 million in the United States [4].…”

Rare disease-based scientific annotation knowledge graph

“…Notably, 80% of patients are affected by ~350 RDs, and the other 20% are affected by the rest of the 7,000 RDs 1 . Most RDs are associated with low prevalence rate (Shourick et al, 2021 ), some being exceptionally rare. For instance, Adrenomyodystrophy (GARD: 0000562) is an extremely rare genetic endocrine disease characterized by primary adrenal insufficiency and hepatic steatosis.…”

Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision

“…In 2021, a rare disease was defined as a disease with an incidence of less than 1/10,000 in newborns, a prevalence of less than 1/10,000, or a condition that affects fewer than 200,000 people in China (3). Currently, there are roughly 7,000 different rare diseases affecting 3.5-5.9% of individuals worldwide, which amounts to 263-446 million individuals (4).…”